Detalhe da pesquisa
1.
Efficacy of ramucirumab combination chemotherapy as second-line treatment in patients with advanced adenocarcinoma of the stomach or gastroesophageal junction after exposure to checkpoint inhibitors and chemotherapy as first-line therapy.
Int J Cancer
; 154(12): 2142-2150, 2024 Jun 15.
Artigo
Inglês
| MEDLINE | ID: mdl-38447003
2.
German, Austrian, and Swiss guidelines for systemic treatment of gastric cancer.
Gastric Cancer
; 27(1): 6-18, 2024 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-37847333
3.
Association between oncologists' death anxiety and their end-of-life communication with advanced cancer patients.
Psychooncology
; 32(6): 923-932, 2023 06.
Artigo
Inglês
| MEDLINE | ID: mdl-37057315
4.
Pazopanib with 5-FU and oxaliplatin as first line therapy in advanced gastric cancer: A randomized phase-II study-The PaFLO trial. A study of the Arbeitsgemeinschaft Internistische Onkologie AIO-STO-0510.
Int J Cancer
; 150(6): 1007-1017, 2022 03 15.
Artigo
Inglês
| MEDLINE | ID: mdl-34741530
5.
Sodium Thiosulfate Reduces Acute Kidney Injury in Patients Undergoing Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy with Cisplatin: A Single-Center Observational Study.
Ann Surg Oncol
; 29(1): 152-162, 2022 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-34350529
6.
Pembrolizumab versus paclitaxel for previously treated PD-L1-positive advanced gastric or gastroesophageal junction cancer: 2-year update of the randomized phase 3 KEYNOTE-061 trial.
Gastric Cancer
; 25(1): 197-206, 2022 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34468869
7.
Efficacy and safety of trifluridine/tipiracil in older and younger patients with metastatic gastric or gastroesophageal junction cancer: subgroup analysis of a randomized phase 3 study (TAGS).
Gastric Cancer
; 25(3): 586-597, 2022 05.
Artigo
Inglês
| MEDLINE | ID: mdl-34997449
8.
Trastuzumab in combination with 5-fluorouracil, leucovorin, oxaliplatin and docetaxel as perioperative treatment for patients with human epidermal growth factor receptor 2-positive locally advanced esophagogastric adenocarcinoma: A phase II trial of the Arbeitsgemeinschaft Internistische Onkologie Gastric Cancer Study Group.
Int J Cancer
; 149(6): 1322-1331, 2021 09 15.
Artigo
Inglês
| MEDLINE | ID: mdl-34019698
9.
Trifluridine/tipiracil in patients with metastatic gastroesophageal junction cancer: a subgroup analysis from the phase 3 TAGS study.
Gastric Cancer
; 24(4): 970-977, 2021 07.
Artigo
Inglês
| MEDLINE | ID: mdl-33713215
10.
Phase III randomized, double-blind study of paclitaxel with and without everolimus in patients with advanced gastric or esophagogastric junction carcinoma who have progressed after therapy with a fluoropyrimidine/platinum-containing regimen (RADPAC).
Int J Cancer
; 147(9): 2493-2502, 2020 11 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32339253
11.
Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial.
Lancet
; 393(10184): 1948-1957, 2019 05 11.
Artigo
Inglês
| MEDLINE | ID: mdl-30982686
12.
Clinical Practice Observation of Trastuzumab in Patients with Human Epidermal Growth Receptor 2-Positive Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction.
Oncologist
; 25(8): e1181-e1187, 2020 08.
Artigo
Inglês
| MEDLINE | ID: mdl-32311799
13.
Ipilimumab or FOLFOX with Nivolumab and Trastuzumab in previously untreated HER2-positive locally advanced or metastatic EsophagoGastric Adenocarcinoma - the randomized phase 2 INTEGA trial (AIO STO 0217).
BMC Cancer
; 20(1): 503, 2020 Jun 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32487035
14.
High thromboembolic event rate in patients with locally advanced oesophageal cancer during neoadjuvant therapy. An exploratory analysis of the prospective, randomised intergroup phase III trial SAKK 75/08.
BMC Cancer
; 20(1): 166, 2020 Feb 28.
Artigo
Inglês
| MEDLINE | ID: mdl-32111181
15.
Evaluation of a communication skills training to facilitate addressing palliative care related topics in advanced cancer patients: study protocol of a multicenter randomized controlled trial (PALLI-KOM).
BMC Palliat Care
; 19(1): 67, 2020 May 12.
Artigo
Inglês
| MEDLINE | ID: mdl-32398130
16.
EORTC-1203-GITCG - the "INNOVATION"-trial: Effect of chemotherapy alone versus chemotherapy plus trastuzumab, versus chemotherapy plus trastuzumab plus pertuzumab, in the perioperative treatment of HER2 positive, gastric and gastroesophageal junction adenocarcinoma on pathologic response rate: a randomized phase II-intergroup trial of the EORTC-Gastrointestinal Tract Cancer Group, Korean Cancer Study Group and Dutch Upper GI-Cancer group.
BMC Cancer
; 19(1): 494, 2019 May 24.
Artigo
Inglês
| MEDLINE | ID: mdl-31126258
17.
The efficacy of treatment options for patients with gastric cancer and peritoneal metastasis.
Gastric Cancer
; 22(6): 1226-1237, 2019 11.
Artigo
Inglês
| MEDLINE | ID: mdl-31065877
18.
Biomarker analysis of the GATSBY study of trastuzumab emtansine versus a taxane in previously treated HER2-positive advanced gastric/gastroesophageal junction cancer.
Gastric Cancer
; 22(4): 803-816, 2019 07.
Artigo
Inglês
| MEDLINE | ID: mdl-30706247
19.
Cytokeratin-18 fragments predict treatment response and overall survival in gastric cancer in a randomized controlled trial.
Tumour Biol
; 40(3): 1010428318764007, 2018 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-29534639
20.
Importance of Pancreatic Enzyme Replacement Therapy after Surgery of Cancer of the Esophagus or the Esophagogastric Junction.
Nutr Cancer
; 70(1): 69-72, 2018 01.
Artigo
Inglês
| MEDLINE | ID: mdl-28945459